ID: MRFR/MED/1882-CR | February 2021 | Region: Global | 104 pages
Based on the study reports, the Saliva Collection and Diagnostics Market are expected to witness a CAGR of 11.17% and it is expected to reach a revenue of USD 5470.08 million during the forecast period (2020-2027).
The past few years have been a fantastic growing time in the Saliva Collection and Diagnostics Market industry. Saliva has an important role in the diagnosis of different diseases. In earlier days, most of the diagnosis was painful and expensive blood tests, later replaced by the more convenient option, saliva test, and diagnosis. The advancement in the Saliva Collection and Diagnostics industry and field has been backed up by many publications supporting the varied and new applications for saliva. The stimulated saliva volume collection has three methods; no stimulation, mechanical and acid stimulation.
The pandemic covid-19 is not all the way gone from our lives, and it has severely impacted all the industries and the global economy. The pandemic mostly had a bad influence on different industries. However, some industries had also profited from the pandemic situation, and the Saliva Collection and Diagnostics Market are one industry.
Saliva being an optimal transitional research tool for diagnostics, the market has gained substantial momentum all across the globe. Saliva collection devices are mostly used to detect periodontitis, breast cancer, salivary gland disease, HIV hepatitis, oral cancer, hepatitis, which boosts the market's growth. The rising demand for saliva collection devices is driving the market key players to invest more in developing products, devices, and kits for testing.
The rising cases of prevalent diseases and the geriatric population suffering from cancer are the driving factors behind the market's growth. The earlier process of a painful blood test being replaced by the saliva collection with a liquid compartment has helped the market grow in many ways.
The growing number of saliva collection devices approvals is creating many opportunities in the market. The cost-effectiveness of the devices is also helping the market to research more and have further developments.
The global Saliva Collection and Diagnostics Market is segmented into-
Based on collection, the Saliva Collection and Diagnostics Market is further segmented into-
Based on application, the Saliva Collection and Diagnostics Market is further segmented into-
The biotechnology segment based on application has the largest market share.
Based on end-user, the Saliva Collection and Diagnostics Market is further segmented into
The hospitals and dental clinics are expected to grow at the highest CAGR of 10.73% during the forecast period. The global market of Devices and Diagnostics Saliva Collection and Diagnostics Market is growing at a significant rate. The general practice segment had a revenue of USD 11,940.9 million in 2016, which is expected to reach USD 11,940.9 million during the forecast period.
Based on region, the Saliva Collection and Diagnostics Market is further segmented into-
The rising number of low-cost general practice clinics worldwide is the key factor behind the huge growth of this segment. In the global Saliva Collection and Diagnostics Market, North America is the most dominating segment based on region. The market is expected to have a revenue of 1268.7 million during the forecast period. It is also the fastest growing country with an expected CAGR rate of 10.02% during the forecast period (2016-2022).
The regional market of Saliva Collection and Diagnostics is divided into the Americas, Europe, APAC, and the Middle East, and Africa.
North America is expected to dominate the global market of Saliva Collection and Diagnostics owing to the innovations in technology and devices for disease testing usage and the rising prevalence of chronic diseases. U. S and Canada are the most dominating countries among all the other countries in the North American market.
Europe is likely to hold the second-largest place in the global Saliva Collection and Diagnostics market. This regional market is sub-segmented into Eastern Europe and Western Europe. The Western European market for Saliva Collection and Diagnostics is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The government initiatives, along with a vast population suffering from cancer, are propelling the market growth of Saliva Collection and Diagnostics.
APAC is expected to witness the fastest growing region during the forecast period. The rising healthcare facilities in India, China, and Japan and the geriatric population suffering from cancer and many other diseases drive the Asia-Pacific Saliva Collection and Diagnostics market.
The Middle East and Africa Saliva collection and diagnostic market are expected to exhibit a steady growth throughout the forecast period.
The global Saliva Collection and Diagnostics Market are anticipated to exhibit steady and considerable growth during the forecast period. Many key players present in the market are adopting new strategies, which boosts the market growth of Saliva Collection and Diagnostics. The supply chain management integration has a strong effect on the growing level of the market. The observation of the evolution pattern and understanding the customer preference is the key reason behind the vast growth of the market. Additionally, service and product improvement are some of the major factors behind the rising productivity and trends behind the market. Moreover, product diversification has helped the industry achieve a vast number of customers in the Saliva Collection and Diagnostics Market.
January, 2020- FDA General Use Clearance was announced by DNA Genotek for products of the Oragene family. Oragene Dx products are used in the non-invasive collection of saliva samples for in vitro diagnostic testing of human DNA.
October 2018- The Edmonton Police Service announced buying and adopting roadside testing machines to detect marijuana consumption. The Edmonton Police announced to procure the DragonTest 5000, a device to measure THC (tetrahydrocannabinol, the main psychoactive compound in cannabis), amphetamines and cocaine levels present in saliva. The Canadian federal government has recently adopted these devices.
Major key players
Many key players present in the market contribute to the Saliva Collection and Diagnostics Market in different ways. Here are some of the prominent key players who have the highest contribution to the market's growth.
The report comprises of
|Market Size||USD 5,470.08 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Collection, Application and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Neogen Corporation. (US)., SARSTEDT AG & Co. KG (Germany), Quest Diagnostics (US), OraSure Technologies (US), and Abbott Laboratories (US)|
|Key Market Opportunities||Saliva-based poct devices|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The projected CAGR would be 11.17% during the forecast period.
The market valuation of USD 5,470.08 Million by 2027.
The valuation was USD 1,633.5 million.
The largest segment was biotechnology in 2017.
The biotechnology valuation was USD 878.5 million.